<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two examples of hematological toxicity following phenylbutazone therapy are described, one of <z:mp ids='MP_0000334'>agranulocytosis</z:mp> and one of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the first case, <z:chebi fb="2" ids="8378">prednisolone</z:chebi> in a dosage of 20 mg. daily restored neutrophil percentage and the total leukocyte count to <z:mpath ids='MPATH_458'>normal</z:mpath>, but the patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, having shown no response to <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy, became dependent on repeated blood transfusion.The English literature on the hematological toxicity of phenylbutazone is reviewed </plain></SENT>
<SENT sid="2" pm="."><plain>Ten fatal cases of <z:mp ids='MP_0000334'>agranulocytosis</z:mp> have been recorded, as have eight cases of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, of which five proved fatal </plain></SENT>
<SENT sid="3" pm="."><plain>Other toxic effects noted have included <z:hpo ids='HP_0001882'>leukopenia</z:hpo>, <z:hpo ids='HP_0000716'>depression</z:hpo> of erythropoiesis, <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>